IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers

AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the US for the treatment of adult ...
Indiatimes

Nutritionist reveals drinking this 4-ingredient shot will reduce the risk of cancer

Nutritionist Dr Shilpa Arora shares a simple yet powerful 4-ingredient morning shot that may help lower cancer risk and promote overall wellness. Made with very commonly available kitchen items, this ...